Establishment Labs Holdings Inc. ESTA
66.49 USD +5.09 (+8.29%)
Nov 4, 2026, 1:15 PM EST
64.41 Day range 67.30
52.25 52-week range 97.59
- YTD
- -8.77%
- 1 year
- +34.60%
- Market cap
- 1.98B
- Revenue (ttm)
- 264.03M
- Profit margin
- -14.56%
- EPS (ttm)
- -1.27
- Shares out
- 29.80M
- Forward P/E
- -282.30
- YTD return
- -8.77%
- 1-year return
- +34.60%
- Volume
- 188.13K
- Avg volume
- 455.41K
- Open
- 64.41
- Previous close
- 61.40
- Day's range
- 64.41 – 67.30
- 52-week range
- 52.25 – 97.59
- Beta
- 1.00
- Analysts
- Strong Buy
- Price target
- 98.00 (+47.4%)
- Earnings date
- Feb 23, 2027
6M -4.59 (-6.47%)
Key statistics
- Enterprise value
- 2.05B
- PEG ratio
- 0.00
- Price / sales
- 6.93
- Price / book
- 119.92
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 33.90%
- Free cash flow
- -11.51M
- Total cash
- 75.81M
- Total debt
- 269.53M
- Return on equity
- -240.66%
- Short % of float
- 16.84%
- 50-day average
- 66.83
- 200-day average
- 72.36
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 98.00 +47.4% upside
Now 66.49
- Target (low)
- 90.00
- Target (mean)
- 98.00
- Target (high)
- 105.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy2
- Buy8
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 23, 2027
Expected Feb 23, 2027. Consensus EPS estimate -0.16.
Financials — quick view
ESTA Revenue — quarterly 67.54M
ESTA Net income — quarterly -11.75M
ESTA EPS — quarterly -0.39
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 23, 2027 | Dec 30, 2026 | -0.18908 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | -0.25682 | -0.35 | -0.09 | -36.28% |
| Aug 6, 2026 | Jun 30, 2026 | -0.33684 | -0.39 | -0.05 | -15.78% |
| May 6, 2026 | Mar 31, 2026 | -0.35495 | -0.40 | -0.05 | -12.69% |
| Feb 24, 2026 | Dec 31, 2025 | -0.215 | -0.09 | +0.13 | +58.14% |
| Nov 5, 2025 | Sep 30, 2025 | -0.54 | -0.38 | +0.16 | +29.63% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | BTIG | main | Buy | Buy |
| Oct 26, 2026 | TD Cowen | main | Buy | Buy |
| Oct 15, 2026 | TD Cowen | reit | Buy | Buy |
| Sep 1, 2026 | BTIG | reit | Buy | Buy |
| Aug 13, 2026 | Citigroup | up | Neutral | Buy |
| Aug 7, 2026 | JP Morgan | main | Overweight | Overweight |
About Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- establishmentlabs.com
News
Baron Discovery Fund Q3 2026 Portfolio Activity 
BTIG Maintains Buy on Establishment Labs Hldgs, Lowers Price Target to $93 
Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript 
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates 
What Establishment Labs (ESTA) Said on Its Q3 Earnings Call 
Establishment Labs Hldgs Q3 2026 Earnings Call Transcript 
Establishment Labs Hldgs Q3 EPS $(0.35) Misses $(0.26) Estimate, Sales $71.993M Beat $66.460M Estimate 
Establishment Labs® Reports Third Quarter 2026 Financial Results 
TD Cowen Maintains Buy on Establishment Labs Hldgs, Lowers Price Target to $95 
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?
Your note
Sign in to keep a note on ESTA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CALDINI FILIPPO | Chief Executive Officer | Stock Award(Grant) | Feb 17, 2026 | 43,430 |
| CHACON QUIROS JUAN JOSE | Director | Sale | May 5, 2026 | 0 |
| CUSTIN ANN | Director | Stock Award(Grant) | Jun 29, 2026 | 24,325 |
| DENHOY RAJ | Chief Financial Officer | Stock Award(Grant) | Mar 12, 2025 | 23,348 |
| GILLIN LESLIE | Director | Stock Award(Grant) | Jun 29, 2026 | 18,594 |
| JW ASSET MANAGEMENT, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | May 27, 2026 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| JW Asset Management, LLC | 9.04% | 2,692,856 | 165.34M | Jun 29, 2026 |
| RTW Investments LP | 8.91% | 2,655,695 | 163.06M | Jun 29, 2026 |
| Blackrock Inc. | 5.31% | 1,582,005 | 97.14M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 5.15% | 1,533,497 | 94.16M | Jun 29, 2026 |
| Brown Advisory Inc. | 4.41% | 1,313,148 | 80.63M | Jun 29, 2026 |
| Findell Capital Management LLC | 3.68% | 1,096,000 | 67.29M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Russell 2000 ETF | 2.35% | 701,297 | 43.06M | Sep 29, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.64% | 489,000 | 30.02M | Jun 29, 2026 |
| LOOMIS SAYLES FUNDS II-Loomis Sayles Small Cap Growth Fund | 1.55% | 461,057 | 28.31M | Jun 29, 2026 |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 1.30% | 387,800 | 23.81M | Jun 29, 2026 |
| Putnam Funds Trust-Putnam Small Cap Growth Fund | 1.27% | 379,035 | 23.27M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.99% | 296,332 | 18.19M | Aug 30, 2026 |